PHARMACOKINETIC INTERACTION BETWEEN PROPRANOLOL AND CHLORPROMAZINE IN SCHIZOPHRENIC PATIENTS
- 1 November 1980
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 316 (8201), 978
- https://doi.org/10.1016/s0140-6736(80)92135-2
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Propranolol in Chronic Schizophrenia: A Controlled Study in Neuroleptic-Treated PatientsThe British Journal of Psychiatry, 1980
- Lysine Fluxes across the Jejunal Epithelium in Lysinuric Protein IntoleranceJCI Insight, 1980
- BASOLATERAL-MEMBRANE TRANSPORT DEFECT FOR LYSINE IN LYSINURIC PROTEIN INTOLERANCEThe Lancet, 1980
- Clinical state and serum neuroleptic levels measured by radioreceptor assay in schizophreniaAmerican Journal of Psychiatry, 1980
- Inhibition of propranolol metabolism by chlorpromazineClinical Pharmacology & Therapeutics, 1979
- A simple and sensitive radioreceptor assay for antischizophrenic drugs in bloodNature, 1977
- PROPRANOLOL AS AN ADJUNCT TO THE TREATMENT OF SCHIZOPHRENIAThe Lancet, 1977
- Correlation Between Plasma Chlorpromazine and its Metabolites and Clinical Ratings in Patients with Acute Relapse of Schizophrenic and Paranoid PsychosisThe British Journal of Psychiatry, 1977
- Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levelsAmerican Journal of Psychiatry, 1976
- THE RELATIONSHIP OF PLASMA CHLORPROMAZINE TO ITS 7‐HYDROXY AND SULPHOXIDE METABOLITES IN A LARGE POPULATION OF CHRONIC SCHIZOPHRENICSBritish Journal of Clinical Pharmacology, 1974